Back
Invesco S&P 500® Equal Wt Real Estt ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
53
RSPR
Invesco S&P 500® Equal Wt Real Estt ETF
Last Price:
32.24
Seasonality Move:
2.64%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.82
Seasonality Move:
-0.9%
Buy
53
Invesco S&P 500® Equal Wt Real Estt ETF (RSPR)
is a Buy
Is Invesco S&P 500® Equal Wt Real Estt ETF a Buy, Sell or Hold?
- The current Invesco S&P 500® Equal Wt Real Estt ETF [RSPR] share price is $32.65. The Score for RSPR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- RSPR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RSPR Stock Price Chart
What is Invesco S&P 500® Equal Wt Real Estt ETF's stock price today?
-
The Invesco S&P 500® Equal Wt Real Estt ETF share price today is $32.65
The current trend is moderately bearish and RSPR is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
RSPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 57.74 | Buy |
Chaikin Money Flow: | -92026 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.79 - 32.67) | Buy |
Bollinger Bands (100): | (31.3 - 32.56) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.74 | Sell |
Relative Strength Index (14 RSI): | 45.16 | Sell |
Chaikin Money Flow: | -377368 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.89 - 42.13) | Sell |
Bollinger Bands (100): | (40.93 - 48.81) | Sell |
RSPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.58 | Buy |
20-day SMA: | 32.19 | Buy |
50-day SMA: | 31.85 | Buy |
200-day SMA: | 31.14 | Buy |
8-day EMA: | 32.55 | Buy |
20-day EMA: | 32.35 | Buy |
50-day EMA: | 32.12 | Buy |
200-day EMA: | 31.64 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.13 | Sell |
20-day SMA: | 40.38 | Sell |
50-day SMA: | 41.72 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 39.68 | Sell |
20-day EMA: | 40.43 | Sell |
50-day EMA: | 41.92 | Sell |
200-day EMA: | 43.42 | Sell |
Invesco S&P 500® Equal Wt Real Estt ETF Earnings Growth & RSPR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Invesco S&P 500® Equal Wt Real Estt ETF Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |